OCTOBER 2ND, 2018 – Vancouver, British Columbia – Tabu Equity Investments Inc. (the “Company”)
The Company confirms that it has made an approach to REALM DISPENSARIES INC. (REALM) of Alberta regarding an offer for 50% of the company. The Company’s consideration of such an offer is nearing completion, with an investment of $1,500,000 representing 50% of REALM.
REALM and TABU will together roll out a minimum of 6 locations in Alberta, with the focus being a Canada wide expansion. The first location in Edmonton Alberta is already being developed, with an expected opening sometime in November of this year. The goal of the JV is to establish 2 stores per month across Canada over the next 2 years. TABU also expects to look internationally as the brand further develops and matures. The company may expedite this expansion by way of acquisition, predicated of course on finding an appropriate relationship or target acquisition. A minimum of 40 to 50 stores are expected to be in operation across Canada by the end of 2020.
The Company continuously considers various options aiming to accelerate its growth, focusing on prioritized areas of distribution , research and medicinal product development. The Company believes that a potential transaction with REALM presents an opportunity to advance the Company’s stated vision, build on its current momentum, and create a value-based cannabis product development and sales leader.
Tabu has also partnered with The DealRoom to offer new investors an opportunity to work with TABU. http://www.stockhouse.com/dealroom . Tabu is raising $2,000,000 utilizing the Deal Room platform, with proceeds going to the continued roll-out of REALM dispensaries.
New developments and information include:
• Tabu/Realm to open first BC store in North Vancouver
• Tabu/Realm actively searching Toronto/Yorkville for future sites
• First Realm store in Edmonton expected to open by end of November with 2 more by February
• Store revenues expected to range between $3,000,000 – $5,000,000 per store, per year
• Store visits between 150 and 200 per store, serving 8000 customers each day by 2020
• Tabu will distribute over 50 new products containing CBD after legalization
• First to sign with Cannavolve, selling to government distributors across Canada
• Revised go public plans to be announced shortly
• Tabu is exploring relationships with iconic international brands
This announcement is not intended to, and does not, constitute, represent or form part of any offer, invitation or solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER ANY CANADIAN RULES REGARDING TAKEOVERS AND MERGERS. THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, OR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE.
Tabu Equity Investments Inc. invests in Canadian ACMPR applicants and licensed United States cannabis technology companies, as well as Canadian based support technologies for the cannabis industry. The company website can be found at: www.tabu.co
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Tabu’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should, aware” and similar expressions, are forward looking statements. Forward-looking statements may include, without limitation, statements including statements related to Tabu’s transactions and business related to cannabis and future news releases. Although Tabu has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.